Suchergebnisse - "Ayşe Gök"

PubPharm (25)

1

The comparison of FOLFOX regimens with different doses of 5-FU for the adjuvant treatment of colorectal cancer : a multicenter study

enthalten in: International journal of colorectal disease | 2021

von Akdeniz, N. | Kaplan, M. | Uncu, D. | +17

2

The comparison of FOLFOX regimens with different doses of 5-FU for the adjuvant treatment of colorectal cancer: a multicenter study

enthalten in: International journal of colorectal disease | 2021

von Akdeniz, N. | Kaplan, M. | Uncu, D. | +17

3

The comparison of FOLFOX regimens with different doses of 5-FU for the adjuvant treatment of colorectal cancer: a multicenter study

enthalten in: International journal of colorectal disease | 2021

von Akdeniz, N. | Kaplan, M. | Uncu, D. | +17

4

The comparison of FOLFOX regimens with different doses of 5-FU for the adjuvant treatment of colorectal cancer: a multicenter study

enthalten in: International journal of colorectal disease | 2021

von Akdeniz, N. | Kaplan, M. | Uncu, D. | +17

5

COVID-19 Outbreak and Depression in the Framework of Emotional Focused Therapy Approach

in: Psikiyatride Güncel Yaklaşımlar | 2021

von Ayşe Gök

6

Positive and negative affect during a pandemic: Mediating role of emotional regulation strategies

in: Journal of Pedagogical Research | 2020

von Ahmet Kara | Ayşe Gök

7

Outcomes of Adolescent and Adult Patients with Lung Metastatic Osteosarcoma and Comparison of Synchronous and Metachronous Lung Metastatic Groups.

in: PLoS ONE | 2016

von Ayse Gok Durnali | Fatma Paksoy Turkoz | Fisun Ardic Yukruk | +8

8

Clinical outcomes in patients who received lapatinib plus capecitabine combination therapy for HER2-positive breast cancer with brain metastasis and a comparison of survival with those who received trastuzumab-based therapy : a study by the Anatolian Society of Medical Oncology

enthalten in: Breast cancer (Tokyo, Japan) | 2014

von Kaplan, M. | Isikdogan, A. | Koca, D. | +22

9

Clinical outcomes in patients who received lapatinib plus capecitabine combination therapy for HER2-positive breast cancer with brain metastasis and a comparison of survival with those who received trastuzumab-based therapy: a study by the Anatolian Society of Medical Oncology

enthalten in: Breast cancer | 2014

von Kaplan, M. | Isikdogan, A. | Koca, D. | +22

10

Clinical outcomes in patients who received lapatinib plus capecitabine combination therapy for HER2-positive breast cancer with brain metastasis and a comparison of survival with those who received trastuzumab-based therapy: a study by the Anatolian Society of Medical Oncology

enthalten in: Breast cancer | 2013

von Kaplan, M. | Isikdogan, A. | Koca, D. | +22